TXN2
From Wikipedia, the free encyclopedia
Thioredoxin 2
|
||||||||||||||
PDB rendering based on 1uvz. | ||||||||||||||
Available structures: 1uvz, 1w4v, 1w89 | ||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | TXN2; TRX2; MT-TRX; MTRX | |||||||||||||
External IDs | OMIM: 609063 MGI: 1929468 HomoloGene: 40849 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 25828 | 56551 | ||||||||||||
Ensembl | ENSG00000100348 | ENSMUSG00000005354 | ||||||||||||
Uniprot | Q99757 | P97493 | ||||||||||||
Refseq | NM_012473 (mRNA) NP_036605 (protein) |
NM_019913 (mRNA) NP_064297 (protein) |
||||||||||||
Location | Chr 22: 35.19 - 35.21 Mb | Chr 15: 77.74 - 77.76 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Thioredoxin 2, also known as TXN2, is a human gene.[1]
This nuclear gene encodes a mitochondrial member of the thioredoxin family, a group of small multifunctional redox-active proteins. The encoded protein may play important roles in the regulation of the mitochondrial membrane potential and in protection against oxidant-induced apoptosis.[1]
[edit] References
[edit] Further reading
- Wang Z, Zhang H, Li XF, Le XC (2007). "Study of interactions between arsenicals and thioredoxins (human and E. coli) using mass spectrometry.". Rapid Commun. Mass Spectrom. 21 (22): 3658–66. doi: . PMID 17939155.
- Udler M, Maia AT, Cebrian A, et al. (2007). "Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.". J. Clin. Oncol. 25 (21): 3015–23. doi: . PMID 17634480.
- Zhang H, Go YM, Jones DP (2007). "Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress.". Arch. Biochem. Biophys. 465 (1): 119–26. doi: . PMID 17548047.
- Zhou J, Damdimopoulos AE, Spyrou G, Brüne B (2007). "Thioredoxin 1 and thioredoxin 2 have opposed regulatory functions on hypoxia-inducible factor-1alpha.". J. Biol. Chem. 282 (10): 7482–90. doi: . PMID 17220299.
- Oestergaard MZ, Tyrer J, Cebrian A, et al. (2006). "Interactions between genes involved in the antioxidant defence system and breast cancer risk.". Br. J. Cancer 95 (4): 525–31. doi: . PMID 16868544.
- Cebrian A, Pharoah PD, Ahmed S, et al. (2006). "Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.". Cancer Res. 66 (2): 1225–33. doi: . PMID 16424062.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi: . PMID 15489334.
- Collins JE, Wright CL, Edwards CA, et al. (2005). "A genome annotation-driven approach to cloning the human ORFeome.". Genome Biol. 5 (10): R84. doi: . PMID 15461802.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi: . PMID 12477932.
- Damdimopoulos AE, Miranda-Vizuete A, Pelto-Huikko M, et al. (2002). "Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death.". J. Biol. Chem. 277 (36): 33249–57. doi: . PMID 12080052.
- Chen Y, Cai J, Murphy TJ, Jones DP (2002). "Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells.". J. Biol. Chem. 277 (36): 33242–8. doi: . PMID 12032145.
- Dunham I, Shimizu N, Roe BA, et al. (1999). "The DNA sequence of human chromosome 22.". Nature 402 (6761): 489–95. doi: . PMID 10591208.
- Spyrou G, Enmark E, Miranda-Vizuete A, Gustafsson J (1997). "Cloning and expression of a novel mammalian thioredoxin.". J. Biol. Chem. 272 (5): 2936–41. PMID 9006939.